Advanced Filters
noise

neoplasms Clinical Trials

A listing of neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 14,180 clinical trials
D David Barreto, MD

Identifying Patterns in the Breath of Individuals With Breast Cancer

Researchers will compare the breath profiles of women with breast cancer and those without to determine whether there are disease-specific patterns that can be leveraged to facilitate breast cancer detection. Women with mammogram-confirmed dense breast tissues undergoing standard-of-care breast cancer screening will be invited to participate. Those who provide informed …

40 - 74 years of age Female Phase N/A
W Woo Kyung Moon, MD, PhD

Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer

Detection of multifocal, multicentric breast cancer in patients with breast cancer affects surgical decision. Histology-proven additional cancer foci have been reported to be detected in 21.0% to 63.0% of affected breasts in women thought to have localized cancer based on clinical assessment and mammography. Dynamic contrast-enhanced (DCE) MRI is often …

25 years of age Female Phase N/A
Y Yongchang Zhang, MD

Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer

Although several clinical trials provide evidence for efficacy benefit for Checkpoint Inhibitors plus chemotherapy for lung cancer. However, there was rare evidence for clinical evidence in Hunan province.

18 years of age All Phase N/A
J Jennifer Woodard, RN, MPH

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

Project CONTINUITY (Connecting You to Care in the Community) was developed to increase adherence to cervical cancer screening regimens from initial screening to needed follow-up care by (1) providing personalized approaches to improve adherence through the combined use of patient choice for the initial screening method (Pap/HPV co-testing vs. HPV …

25 - 65 years of age Female Phase N/A
A Alexa DeBord, MS

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of …

18 - 89 years of age All Phase N/A
E Enrico Vizza, MD

Application of da Vinci SP for Endometrial Cancer Surgical Staging

Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.

18 years of age Female Phase N/A
X Xiaobo Y Huang, MD

Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer

The purpose of this study is to determine whether certain patients can safely omit regional lymph node radiotherapy. These women must have hormone-sensitive, Her2-negative tumors, have 1-3 positive axillary nodes and have RecurIndex low-risk.

18 - 70 years of age Female Phase N/A
J Julien KIRCHGESNER, MD, PhD

Ibd CAncer and seRious Infections in France (I-CARE 2)

This is a French prospective longitudinal observational multicentre cohort study. Primary objective : to assess prospectively the presence and the extent of safety concerns (cancer, serious infections, arterial and venous thrombotic events) in patients with CD and UC and treated with JAKi, anti-IL23p19, and S1p modulators.

18 - 75 years of age All Phase N/A

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some …

20 - 90 years of age All Phase N/A

Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer

Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a molecular subtype with high malignancy and high risk to recurrence and metastasis. After the appearance of anti-HER2 targeted drugs, the prognosis and survival of these patients were greatly improved. In addition to trastuzumab and pertuzumab, the use of …

years of age All Phase N/A

Simplify language using AI